CG Oncology
CG Oncology is seeking a Vice President of Analytical Development and Quality Control to lead strategic and operational activities supporting clinical development, regulatory submissions, and commercial readiness. The role involves overseeing analytical methods, quality systems, regulatory interactions, and building a high-performing organization to support company growth. This position is critical in ensuring compliance, scientific rigor, and successful product lifecycle management within a patient-centered biotech focus.
CG Oncology is a late-stage biopharmaceutical company focused on developing bladder‑sparing immunotherapies for bladder cancer. The company specializes in oncolytic immunotherapy and is advancing cretostimogene grenadenorepvec as a lead therapeutic candidate. CG Oncology’s programs aim to provide non-surgical, targeted treatment options that preserve the bladder and improve outcomes for patients with bladder cancer. They emphasize clinical development and commercialization readiness to bring these innovative therapies to market.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CG Oncology.
24% above the average for this role
Principal Scientist, Pharmaceutical Analytical Sciences
Merck & Co., Inc.
Principal Scientist, Pharmaceutical Analytical Sciences
Merck & Co., Inc.
Senior Manager, Analytical Chemistry
Enliven
Director, Analytical Development
Arbor
Associate Principal Scientist, Analytical R&D
MSD
Director, Analytical Development and Quality Control
kaileratherapeutics